Tous Actualités
Suivre
Abonner LifeWatch AG

LifeWatch AG

EANS-Adhoc: LIFEWATCH AND TRACKER ANNOUNCE JOINT-VENTURE. LifeWatch products now also available in Switzerland. (with document)

Un document

--------------------------------------------------------------------------------
  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
--------------------------------------------------------------------------------
Company Information/LifeWatch AG

23.11.2011

Neuhausen am Rheinfall/Rüschlikon - LifeWatch AG (SIX Swiss Exchange: LIFE),
the leading provider of wireless telemedicine and other monitoring services in
the U.S., and Tracker (Tracker.ch AG), the leading Swiss provider for Internet
tracking solutions using GPS and GPRS technology, today announced a joint
venture. This cooperation gives LifeWatch exclusive access to the tracking
technology developed by Tracker and to all established distribution channels of
Tracker. Thus LifeWatch can further strengthen its market position. A first
product named LifeTracker, which the two companies developed together, will
already be launched in December 2011. Another innovative product launch is
scheduled for the first quarter 2012.

You will find a PDF-version of this press release at the end of this message.

The joint venture announced today represents a strategic milestone in the
history of both companies. It opens up new development perspectives for both
partners who are market leaders in their respective industry and markets. For
LifeWatch this is the first major market entry outside the U.S. and an
important step toward more geographic diversification. LifeWatch Europe AG, a
100% subsidiary of LifeWatch AG, will hold 51% ownership and Tracker 49%.

With this joint venture LifeWatch AG gains exclusive access to the machine-to-
machine (M2M) based tracking-technology developed by Tracker.com. M2M solutions
represent currently the biggest growth market in ICT. Additionally, LifeWatch
gains access to all established distribution channels (Wholesale, retail and
specialty stores) of Tracker in Switzerland. Furthermore negotiations with
reputable institutions of the Swiss healthcare industries are under way. During
the fist phase the joint venture will focus only on the Swiss market. The
second phase is dedicated to the market entry into the neighbouring European
healthcare markets. Moreover LifeWatch can rely on the long standing know how
of Guido Honegger´s solution.ch group (soluction.ch AG, Tracker.com, Nexphone
AG, iway AG). Solution.ch and its group companies cover all needs of modern
ICT. Thus the joint venture will contribute to the value chain of both
companies.

A first product developed together will be launched into the market under the
product brand LifeTracker in December 2011. LifeTracker is an innovative cell
phone targeted at people aged 60 and over. A next product launch is expected
for the first quarter 2012. Using this product the client can chose among
several features from a modular package satisfying his specific needs. At the
same time this device, which is a virtual phone app for android smart phones,
will break the ground for new solutions in medical data transfer via M2M
technology. The app enables via Bluetooth the direct transfer of hypertension
and diabetes data from measuring devices on the virtual phone to medical
organizations or physicians. With this advanced data transfer technology the
Company creates a significant and noticeable added value for patients,
physicians, clinics and labs. The automation of medical data transfer processes
can make a considerable contribution to lowering costs in the Swiss federal
healthcare system. With its long-standing experience in the U.S. market, Life
Watch is particularly well positioned to help lower healthcare costs.


About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall, Switzerland and listed
on SIX Swiss Exchange (LIFE), is the leading healthcare technology and
solutions company, specializing in advanced telemedicine systems and wireless
remote patient monitoring services. LifeWatch provides services to high-risk
and chronically ill patients, health conscious consumers and wellness programs.
LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the
United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of
LifeWatch Services, Inc., a leading US-based wireless remote telemedicine
provider. LifeWatch services include Home Sleep Testing for Obstructive Sleep
Apnea patients under the brand name NiteWatch. For additional information,
please visit www.lifewatch.com.


About Tracker.com:

Tracker.com develops and markets innovative global functioning Internet
tracking solutions using GPS and GPRS technology. Solutions developed by
Tracker.com are suitable for numerous applications and are characterized by an
intuitive and easy operation. The main application areas of the Tracker.com
solutions are logistics and objects as well as the localization of humans and
animals and applications for sport. Our solutions are continually developed and
comply with the latest technology standards. A free Tracker.com iPhone and
Android App is also available. Tracker.ch AG is a member of the Solution.ch
group and was founded in May 2010. CEO of tracker.ch AG is Guido Honegger.

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position,
business strategy and plans and objectives for future operations, are forward-
looking statements. The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended to
identify forward-looking statements. LifeWatch AG has based these forward-
looking statements largely on current expectations and projections about future
events and financial trends that it believes may affect the financial condition,
results of operations, business strategy, short term and long term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the forward-
looking statements. All forward-looking statements are based only on data
available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT
CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES
FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION,
THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR
DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER
OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED
STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE
UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM
LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/BdZOgnI9

Further inquiry note:
Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email  lifewatch@sensus.ch

or:

Vladi Barrosa

Barrosa Communication AG

T : 043 521 85 00

F : 043 521 85 01

M: 079 430 77 61
 
vladi.barrosa@barrosa.ch

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/BdZOgnI9


issuer:      LifeWatch AG
             Rundbuckstrasse 6
             CH-8212 Neuhausen am Rheinfall
phone:       +41 52 632 00 50
FAX:         +41 52 632 00 51
mail:         users@lifewatch.com
WWW:      www.lifewatch.com
sector:      Healthcare Providers
ISIN:        CH0012815459
indexes:     SPI, SPIEX
stockmarkets: Open Market / XETRA: Frankfurt, free trade: Berlin, Main Standard:
             SIX Swiss Exchange 
language:   English

Plus de actualités: LifeWatch AG
Plus de actualités: LifeWatch AG